Skip to content
Cultural Foundation
Author:
Climb Bio, Inc.
Climb Bio Hosts Budoprutug R&D Spotlight Event Highlighting Topline Subcutaneous Formulation Data, Broad B-Cell Mediated Disease Opportunity, and Upcoming Data Readouts
May 5, 2026
Climb Bio, Inc. Announces $110.0 Million Private Placement
April 28, 2026
←
Previous Page
1
2